|
Status |
Public on May 13, 2014 |
Title |
UPN727 cells, auto-antibody-negative (AA-) low HLA risk sibling Longitudinal non-progressor series plasma LoLRn31 |
Sample type |
RNA |
|
|
Source name |
UPN727 cells stimulated with auto-antibody-negative (AA-) low HLA risk sibling Longitudinal non-progressor series plasma
|
Organism |
Homo sapiens |
Characteristics |
responder pbmc cells: UPN727 PBMC cells stimulated with: auto-antibody-negative (AA-) low HLA risk sibling Longitudinal non-progressor series plasma
|
Treatment protocol |
Gene expression was accomplished by culturing PBMCs at 37°C in 5% CO2 with 40% of longitudinal, healthy high HLA type T1D sibling (HR), healthy low HLA type T1D sibling (LR), or recent onset (RO) T1D plasma cultured with IL1RA. Cultures were prepared in a Costar 24-well plate (Corning) using 500,000 cells/well and in RPMI 1640 medium supplemented with 100U/ml penicillin and 100ug/ml streptomycin in a total of 500 µl. After culture (9 hours optimal for cryopreserved PBMCs) total RNA was extracted using TRIzol reagent (Invitrogen Life Technologies).
|
Growth protocol |
Commercial cryopreserved PBMCs of healthy Caucasian male donor UPN727 were thawed and washed per the manufacturer’s protocol (Cellular Technology Ltd., Shaker Heights, OH).
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was extracted and amplified using an Affymetrix two-cycle cDNA synthesis kit (Affymetrix, Santa Clara, CA).
|
Label |
biotin
|
Label protocol |
cRNA was synthesized, labeled, fragmented, and hybridized to an array in accordance to the Affymetrix GeneChip expression analysis technical manual.
|
|
|
Hybridization protocol |
The GeneChip human genome U133 plus 2.0 array was selected for these studies for its overall comprehensive coverage.
|
Scan protocol |
After hybridization, arrays were washed and stained with Affymetrix fluidics protocol FS450_0001 and scanned with a 7G Affymetrix GeneChip Scanner
|
Description |
LoLRn31 Gene expression data from UPN727 cells stimulated with auto-antibody-negative (AA-) low HLA risk sibling Longitudinal non-progressor series plasma
|
Data processing |
Image data were normalized and analyzed Partek Genomic Suite (Partek GS) to determine signal log intensity/ratios. The statistical significance of differential gene expression and false discovery rates (FDR) were derived through ANOVA function in Partek GS.
|
|
|
Submission date |
Nov 25, 2013 |
Last update date |
May 13, 2014 |
Contact name |
Martin Hessner |
E-mail(s) |
[email protected]
|
Organization name |
Medical College of Wisconsin
|
Department |
Pediatrics
|
Lab |
Max McGee National Research Center for Juvenile Diabetes
|
Street address |
8701 Watertown Plank Road
|
City |
Milwaukee |
State/province |
WI |
ZIP/Postal code |
53226 |
Country |
USA |
|
|
Platform ID |
GPL570 |
Series (1) |
GSE52724 |
Molecular signatures differentiate immune states in Type 1 Diabetes families |
|